US Stock MarketDetailed Quotes

APRE Aprea Therapeutics

Watchlist
  • 5.375
  • +0.205+3.96%
Trading Apr 25 11:41 ET
29.19MMarket Cap-1360P/E (TTM)

Aprea Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-58.60%15.47M
38.59%3.67M
-16.13%3.52M
-83.73%3.65M
-42.75%4.62M
-0.20%37.37M
-66.13%2.65M
-55.46%4.2M
124.51%22.45M
-20.75%8.07M
Selling and administrative expenses
-59.81%8.43M
-22.49%1.64M
-44.21%1.72M
-89.13%1.7M
-15.54%3.37M
54.75%20.97M
-37.02%2.12M
-9.73%3.08M
367.61%15.63M
16.33%3.99M
-General and administrative expense
-59.81%8.43M
-22.49%1.64M
-44.21%1.72M
-89.13%1.7M
-15.54%3.37M
54.75%20.97M
-37.02%2.12M
-9.73%3.08M
367.61%15.63M
16.33%3.99M
Research and development costs
-53.50%7.63M
284.96%2.05M
89.93%2.12M
-67.66%2.2M
-69.27%1.26M
-31.36%16.4M
-88.09%531.41K
-81.42%1.12M
2.36%6.81M
-39.54%4.09M
Other operating expenses
---583.23K
---14.08K
---319.47K
---249.69K
----
----
----
----
----
----
Operating profit
58.60%-15.47M
-38.59%-3.67M
16.13%-3.52M
83.73%-3.65M
42.75%-4.62M
0.20%-37.37M
66.13%-2.65M
55.46%-4.2M
-124.51%-22.45M
20.75%-8.07M
Net non-operating interest income expense
172.84%1.22M
27.65%310.29K
112.55%321.22K
540.53%336.22K
12,909.13%256.41K
27,124.94%448.67K
7,208.54%243.08K
458,048.48%151.12K
9,027.04%52.49K
286.47%1.97K
Non-operating interest income
172.84%1.22M
27.65%310.29K
112.55%321.22K
540.53%336.22K
----
27,124.94%448.67K
--243.08K
--151.12K
--52.49K
----
Total other finance cost
----
----
----
----
-12,909.13%-256.41K
----
----
----
----
-286.47%-1.97K
Other net income (expense)
99.95%-38.93K
-133.99%-78.61K
-111.83%-2.88K
100.07%56.36K
-110.13%-13.8K
-23,962.06%-75.74M
-147.88%-33.6K
211.17%24.35K
-29,905.03%-75.87M
-73.91%136.21K
Gain on sale of security
-113.83%-38.93K
-133.99%-78.61K
-111.83%-2.88K
-63.53%56.36K
-110.13%-13.8K
-11.30%281.53K
-147.88%-33.6K
211.17%24.35K
161.13%154.57K
-73.91%136.21K
Special income (charges)
--0
--0
--0
--0
----
---76.02M
--0
--0
---76.02M
----
-Less:Other special charges
----
----
----
----
----
--76.02M
--0
----
--76.02M
----
Income before tax
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
Income tax
Net income
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
Net income continuous Operations
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
Minority interest income
Net income attributable to the parent company
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
87.32%-14.29M
-40.99%-3.44M
20.38%-3.2M
96.68%-3.26M
44.81%-4.38M
-203.45%-112.66M
68.51%-2.44M
57.42%-4.02M
-858.52%-98.26M
17.91%-7.94M
Basic earnings per share
94.19%-3.95
0.00%-0.92
62.93%-0.86
99.00%-0.87
81.52%-1.34
-94.93%-67.99
87.22%-0.92
74.22%-2.32
-803.33%-86.72
21.20%-7.25
Diluted earnings per share
94.19%-3.95
0.00%-0.92
62.93%-0.86
99.00%-0.87
81.52%-1.34
-94.93%-67.99
87.22%-0.92
74.22%-2.32
-803.33%-86.72
21.20%-7.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -58.60%15.47M38.59%3.67M-16.13%3.52M-83.73%3.65M-42.75%4.62M-0.20%37.37M-66.13%2.65M-55.46%4.2M124.51%22.45M-20.75%8.07M
Selling and administrative expenses -59.81%8.43M-22.49%1.64M-44.21%1.72M-89.13%1.7M-15.54%3.37M54.75%20.97M-37.02%2.12M-9.73%3.08M367.61%15.63M16.33%3.99M
-General and administrative expense -59.81%8.43M-22.49%1.64M-44.21%1.72M-89.13%1.7M-15.54%3.37M54.75%20.97M-37.02%2.12M-9.73%3.08M367.61%15.63M16.33%3.99M
Research and development costs -53.50%7.63M284.96%2.05M89.93%2.12M-67.66%2.2M-69.27%1.26M-31.36%16.4M-88.09%531.41K-81.42%1.12M2.36%6.81M-39.54%4.09M
Other operating expenses ---583.23K---14.08K---319.47K---249.69K------------------------
Operating profit 58.60%-15.47M-38.59%-3.67M16.13%-3.52M83.73%-3.65M42.75%-4.62M0.20%-37.37M66.13%-2.65M55.46%-4.2M-124.51%-22.45M20.75%-8.07M
Net non-operating interest income expense 172.84%1.22M27.65%310.29K112.55%321.22K540.53%336.22K12,909.13%256.41K27,124.94%448.67K7,208.54%243.08K458,048.48%151.12K9,027.04%52.49K286.47%1.97K
Non-operating interest income 172.84%1.22M27.65%310.29K112.55%321.22K540.53%336.22K----27,124.94%448.67K--243.08K--151.12K--52.49K----
Total other finance cost -----------------12,909.13%-256.41K-----------------286.47%-1.97K
Other net income (expense) 99.95%-38.93K-133.99%-78.61K-111.83%-2.88K100.07%56.36K-110.13%-13.8K-23,962.06%-75.74M-147.88%-33.6K211.17%24.35K-29,905.03%-75.87M-73.91%136.21K
Gain on sale of security -113.83%-38.93K-133.99%-78.61K-111.83%-2.88K-63.53%56.36K-110.13%-13.8K-11.30%281.53K-147.88%-33.6K211.17%24.35K161.13%154.57K-73.91%136.21K
Special income (charges) --0--0--0--0-------76.02M--0--0---76.02M----
-Less:Other special charges ----------------------76.02M--0------76.02M----
Income before tax 87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M-858.52%-98.26M17.91%-7.94M
Income tax
Net income 87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M-858.52%-98.26M17.91%-7.94M
Net income continuous Operations 87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M-858.52%-98.26M17.91%-7.94M
Minority interest income
Net income attributable to the parent company 87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M-858.52%-98.26M17.91%-7.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 87.32%-14.29M-40.99%-3.44M20.38%-3.2M96.68%-3.26M44.81%-4.38M-203.45%-112.66M68.51%-2.44M57.42%-4.02M-858.52%-98.26M17.91%-7.94M
Basic earnings per share 94.19%-3.950.00%-0.9262.93%-0.8699.00%-0.8781.52%-1.34-94.93%-67.9987.22%-0.9274.22%-2.32-803.33%-86.7221.20%-7.25
Diluted earnings per share 94.19%-3.950.00%-0.9262.93%-0.8699.00%-0.8781.52%-1.34-94.93%-67.9987.22%-0.9274.22%-2.32-803.33%-86.7221.20%-7.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg